NOVEMBER 2019 SPECIAL MEETING PROXY STATEMENT

Company

BioRestorative Therapies, Inc.

Filed

October 28, 2019

Period of Report

November 13, 2019

Accession Number

0001021771-19-000073

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →